The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 27, 2025
Filed:
Apr. 06, 2023
Applicant:
Wista Laboratories Ltd., Singapore, SG;
Inventors:
Claude Michel Wischik, Aberdeen, GB;
Björn Olaf Schelter, Aberdeen, GB;
Damon Jude Wischik, Cambridge, GB;
John Mervyn David Storey, Aberdeen, GB;
Assignee:
WisTa Laboratories Ltd., Singapore, SG;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5415 (2006.01); A23L 33/105 (2016.01); A23L 33/12 (2016.01); A23L 33/15 (2016.01); A23P 10/28 (2016.01); A23P 10/30 (2016.01); A61K 45/06 (2006.01); A61P 25/28 (2006.01); B65D 75/36 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5415 (2013.01); A23L 33/105 (2016.08); A23L 33/12 (2016.08); A23L 33/15 (2016.08); A23P 10/28 (2016.08); A23P 10/30 (2016.08); A61K 45/06 (2013.01); A61P 25/28 (2018.01); B65D 75/36 (2013.01); A23V 2002/00 (2013.01); B65D 2203/02 (2013.01);
Abstract
The invention provides novel regimens for treatment of neurodegenerative disorders utilising methylthioninium (MT)-containing compounds. The regimens are based on novel findings in relation to the dosage of MT compounds, and their interaction with symptomatic treatments based on modulation of a acetylcholinesterase levels.